RE:RE:RE:Thyroid cancer There is a very basic point here. Everybody knows that if you don't pre-screen for Sortilin then you run the risk of enrolling patients that have no Sortilin. When I say EVERYBODY, I mean EVERYBODY.
We (should) all know this. The oncology experts at the fda over-seeing THTX's file know this. The THTX team know this. Beliveau and Rothenberg know this. The oncology experts at Soleus know this. The docs at clinical sites know this.
Are they all making the same fatal mistake?
JFM "knows" why they should be screening. He can't even begin to consider why they AREN'T ACTUALLY screening. That's his fatal mistake.